Teva Launches Generic Abilify® Tablets in the United States
Apr 28, 2015. We are pleased to launch generic Aripiprazole tablets and offer a generic. had annual sales of approximately $7.8 billion in the United States. Aug 8, 2017. *”Excluding ABILIFY” in this material represents Net sales excluding ABILIFY and Milestone/Upfront revenue. Net Sales. Net Sales by Market. Jan 30, 2014. After aripiprazole, the next best selling drugs in 2013 were Nexium, at $6.1. Rounding out the top 10 in sales were Crestor $5.3 billion.
Top 100 Selling Drugs of 2013 - Medscape
Mar 31, 2015. Otsuka Holdings Co. Ltd. ANNUAL REPORT 20. 1. 5. *1 Net sales excluding ABILIFY and milestone/upfront revenue. * As a result of the. Abilify aripiprazole patent expiry in the US and 5EU in. annual growth rate CAGR of 2.40% over the. Schizophrenia Drug Sales by Region, 2012–2022.
The 5 Top-Selling Drugs In The World Benzinga
Sep 20, 2016. Abilify — $9.3 Billion Annual Sales. Abilify is owned by Otsuka Group and is prescribed for serious mental illnesses such as severe depression. Apr 28, 2015. 18. Otsuka $8.2B △21.0% Global revenue $12.3B 19th; up 14.1% Top brands Abilify $7.8B Promotional spend $361M 18th; 4.4% of rev.